Mustang Bio, Inc. (MBIO) Financial Statements (2024 and earlier)

Company Profile

Business Address 377 PLANTATION STREET
WORCESTER, MA 01605
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments75,656,000109,618,00097,804,00061,413,00034,073,00060,977,000
Cash and cash equivalents75,656,000109,618,00097,804,00061,413,00016,469,00034,975,000
Short-term investments     17,604,00026,002,000
Restricted cash and investments 1,000,0001,000,0001,000,0001,000,000  
Receivables     37,000106,000
Prepaid expense     1,015,000278,000
Other undisclosed current assets2,196,0001,088,000730,000650,000  
Total current assets:78,852,000111,706,00099,534,00063,063,00035,125,00061,361,000
Noncurrent Assets
Operating lease, right-of-use asset2,918,0001,050,0001,088,0001,196,000
Property, plant and equipment9,391,00011,052,0008,028,0007,936,0006,858,000 
Restricted cash and investments1,000,0001,000,0001,000,0001,000,000500,000500,000
Other noncurrent assets261,000362,000250,000250,000271,000251,000
Other undisclosed noncurrent assets      1,381,000
Total noncurrent assets:13,570,00013,464,00010,366,00010,382,0007,629,0002,132,000
TOTAL ASSETS:92,422,000125,170,000109,900,00073,445,00042,754,00063,493,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:13,731,0009,744,0008,747,0005,668,0005,381,0003,474,000
Accounts payable6,833,0003,512,0003,518,0001,877,000  
Other undisclosed accounts payable and accrued liabilities6,898,0006,232,0005,229,0003,791,0005,381,0003,474,000
Debt   278,0001,507,000  
Due to related parties766,000723,000490,000596,000  
Other undisclosed current liabilities612,000348,000  236,000137,000
Total current liabilities:15,109,00010,815,0009,515,0007,771,0005,617,0003,611,000
Noncurrent Liabilities
Long-term debt and lease obligation 27,436,0001,685,0001,950,00014,022,000  
Long-term debt, excluding current maturities 27,436,000  12,179,000  
Liabilities, other than long-term debt3,604,000270,000  741,00050,000
Accounts payable and accrued liabilities     741,00050,000
Deferred revenue270,000270,000  
Operating lease, liability3,334,0001,685,0001,950,0001,843,000
Total noncurrent liabilities:31,040,0001,955,0001,950,00014,022,000741,00050,000
Total liabilities:46,149,00012,770,00011,465,00021,793,0006,358,0003,661,000
Equity
Equity, attributable to parent, including:46,273,000112,400,00098,435,00051,652,00036,396,00059,832,000
Common stock   7,0004,0003,0003,000
Common stock, value, subscriptions1,109,0004,329,0007,939,0004,923,0002,085,0009,558,000
Additional paid in capital374,522,000359,906,000275,963,000172,184,000113,378,00098,679,000
Accumulated deficit(329,369,000)(251,844,000)(185,474,000)(125,459,000)(79,070,000)(48,408,000)
Other undisclosed equity, attributable to parent11,0009,000    
Total equity:46,273,000112,400,00098,435,00051,652,00036,396,00059,832,000
TOTAL LIABILITIES AND EQUITY:92,422,000125,170,000109,900,00073,445,00042,754,00063,493,000

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(76,159,000)(66,723,000)(56,806,000)(45,885,000)(31,223,000)(31,785,000)
Operating loss:(76,159,000)(66,723,000)(56,806,000)(45,885,000)(31,223,000)(31,785,000)
Nonoperating income (expense)(1,366,000)353,000(3,209,000)(504,000)561,000497,000
Other nonoperating income (expense) 353,000    
Interest and debt expense(3,359,000) (3,917,000)(1,767,000)(8,000)(8,000)
Loss from continuing operations:(80,884,000)(66,370,000)(63,932,000)(48,156,000)(30,670,000)(31,296,000)
Loss before gain (loss) on sale of properties:(66,370,000)(63,932,000)(48,156,000)(30,670,000)(31,296,000)
Net loss:(80,884,000)(66,370,000)(63,932,000)(48,156,000)(30,670,000)(31,296,000)
Other undisclosed net income attributable to parent3,359,000 3,917,0001,767,0008,0008,000
Net loss available to common stockholders, diluted:(77,525,000)(66,370,000)(60,015,000)(46,389,000)(30,662,000)(31,288,000)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(80,884,000)(66,370,000)(63,932,000)(48,156,000)(30,670,000)(31,296,000)
Comprehensive loss, net of tax, attributable to parent:(80,884,000)(66,370,000)(63,932,000)(48,156,000)(30,670,000)(31,296,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: